Verona Pharma - ADR Financials

$106.91

$0.00 (0.00%)

As on 07-Oct-2025 09:30EDT

Market cap

$9,085 Mln

Revenue (TTM)

$168 Mln

P/E Ratio

--

P/B Ratio

33

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	167.65	33.77	0.46	0.38	29.58	0.00
Cost of Revenue	8.14	2.06	0.68	0.29	--	0.63
Gross Profit	159.52	31.71	-0.68	0.09	29.58	-0.63
Operating Expenses	202.87	155.21	53.00	62.75	83.79	54.32
Operating Profit (EBIT)	-43.36	-123.51	-53.00	-62.66	-54.21	-54.32
Other Income	--	--	--	--	--	--
Profit before Tax	-56.52	-130.30	-42.28	-56.62	-41.10	-47.53
Provision for Tax	6.58	8.22	0.37	-0.21	0.01	0.11
Profit after Tax (Net Income)	-63.10	-138.52	-42.65	-56.83	-41.09	-47.64
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-68.70	-55.57	-65.15

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	278.27	204.56	249.28	230.47	148.01	184.85
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	243.36	227.00	50.15	9.97	5.16	5.15
Current Liabilities	51.24	42.68	8.69	19.03	33.42	14.20
Total Liabilities	624.11	474.24	308.12	259.47	186.59	204.21

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	24.02	20.67	18.42	16.47	16.52	1.70
Current Assets	548.85	453.57	289.71	243.00	170.06	202.50
Total Assets	624.11	474.24	308.12	259.47	186.59	204.21
Total Debt*	244.37	122.70	51.33	10.65	5.81	5.95
Net Current Assets	497.61	410.89	281.02	223.97	136.64	188.30

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-122.20	-50.22	-59.86	-33.25	-45.08
Cash Flow from Investing Activities	--	-0.58	--	-0.03	-0.01	9.71
Cash from Financing Activities	--	250.78	92.87	140.82	-6.12	192.34
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-0.77	-1.67	-0.53	-0.75	-0.69	-0.82
Cash EPS ($)	--	-1.66	-0.52	-0.74	-0.68	-0.81
Adjusted Book Value ($)	--	2.47	3.11	3.05	2.47	3.20
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.47	-0.63	-0.79	-0.56	-0.78
Free Cash Flow per Share ($)	--	-1.48	-0.63	-0.79	-0.56	-0.78

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-44.12	-15.75	-28.78	-23.85	-40.29
ROE (%)	-26.14	-61.04	-17.78	-30.03	-24.69	-41.56
ROA (%)	-11.40	-35.41	-15.03	-25.48	-21.03	-36.17
EBIT Margin (%)	-24.88	-357.22	-11,383.65	-14,435.84	-144.21	-2,053,160.87
Net Margin (%)	-37.64	-410.18	-9,311.94	-15,000.25	-138.92	-2,026,287.20
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	17,734.47	72.73	0.21	-0.99	12,580.37	--
EBIT Growth (%)	59.24	-131.37	4.67	-28.22	11.63	-48.29
Net Profit Growth (%)	36.65	-224.78	24.96	-38.30	13.74	-55.58
EPS Growth (%)	37.32	-2.14	0.29	-0.10	0.17	0.65
Book Value Growth (%)	47.40	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-27.80	-37.42	-34.73	-9.80	-8.50
Price / Book Value	33.01	18.82	6.40	8.56	2.72	2.19
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-20.89	-29.83	-26.65	-32.42	-6.16	-4.45
Close Price ($)	94.58	46.44	19.88	26.13	6.72	7.00
High Price ($)	99.00	47.28	26.44	26.23	9.72	15.71
Low Price ($)	14.15	11.40	11.83	3.41	3.66	2.01
Market Cap ($ Cr)	9,085.09	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	0.87	0.60	0.21	0.05	0.04	0.03
Short term debt to equity ratio	0.00	0.01	0.00	0.00	0.00	0.01
Current Ratio	10.71	10.63	33.33	12.77	5.09	14.26
Quick Ratio	10.54	10.48	33.33	12.64	4.97	13.94
Interest Coverage	-0.52	-5.12	-25.25	-104.98	-125.46	-1,379.14

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	51.84	110.33	2,391.70	2,449.94	52.68	351,339.86
Asset Turnover	0.30	0.09	0.00	0.00	0.15	0.00
Receivable days	--	260.73	8,068.99	11,985.69	147.21	1,403,983.09
Inventory Days	--	553.36	671.52	4,170.38	--	2,339.55
Payable days	--	1,306.85	1,720.31	8,265.46	--	613.46
Cash Conversion Cycle	--	-492.76	7,020.20	7,890.60	--	1,405,709.19

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.